Mishra R, Upadhyay A (2025) An update on mammalian and non-mammalian animal models for biomarker development in neurodegenerative disorders
The cardioprotective mechanisms of GLP-1 RAs are thought to involve a combination of anti-inflammatory and antioxidant actions, reduced secretion of atherogenic lipoproteins, improved vascular endothelial function, and blood pressure regulation 32,33
This combination works in a very different, more physiologic way, and understanding that difference is the key to using it responsibly
For the bigger picture, read how supervised peptide therapy at Perfect B in Doral is structured and how it supports safe, monitored use of peptides
The Brazilian market for GLP-1 agonists, which includes semaglutide, is estimated at around US$1.8 billion